Matthew T. Wiley - Insider Trading & Ownership

Location
C/O Foamix Pharmaceuticals Ltd., 2 Holtzman St, Weizmann Science Park, Rehovot, Israel
Summary
The estimated net worth of Matthew T. Wiley is at least $269K dollars as of March 18, 2025. Matthew T. Wiley is the Chief Commercial Officer of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $249K. Matthew T. Wiley is the Chief Commercial Officer of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $20.1K.
Signature
/s/Mark Sullivan, Attorney-in-Fact for Matthew T. Wiley
All Insider Reports
All Insider Reports

Ownership of Matthew T. Wiley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VYNE VYNE Therapeutics Inc. Chief Commercial Officer $249K Jun 30, 2021
BTAI BioXcel Therapeutics, Inc. Chief Commercial Officer $20.1K Sep 17, 2024
MNMD Mind Medicine (MindMed) Inc. Chief Commercial Officer Mar 17, 2025

Insider Transactions Reported by Matthew T. Wiley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.